Treatment of cardiac hypertrophy using interferon-gamma
CA 2325442 C · Owner: Jin, Hongkui · Inventors: Yang, Renhui; Paoni, Nicholas J.; Jin, Hongkui
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns the treatment of cardiac hypertrophy by interferongamma (IFN-.gamma.). Cardiac hypertrophy may result from a variety of diverse pathologic conditions, including myocardial infarction hypertension, hypertrophic cardiomyopathy and valvular regurgitation. The treatment extends to all stages of the progression of cardiac hypertrophy with or without , structural damage of the heart muscle regardless of the underlying cardiac , disorder.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 19, 1999 and granted October 11, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 19, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 19, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.